We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
RANKL/OPG axis as a therapeutic target for microplastic-induced bone loss: Mechanistic insights from transcriptomic and functional validation
AI summary Read the abstract
This study found microplastic deposits in human bone tissue and showed that MPs disrupt bone metabolism by altering the RANKL/OPG signaling axis, a key regulator of bone remodeling. Transcriptomic and functional analyses identified therapeutic target pathways that could potentially protect against microplastic-induced bone loss.
Although plastic products have offered substantial benefits to modern society and daily life, their degradation into microplastics (MPs) has raised significant concerns owing to their adverse effects on ecosystems and human health. This study investigated MP deposition in human skeletal tissues and elucidated their effects on bone metabolism. Comprehensive analysis of human bone tissue using Nile red staining, Raman spectroscopy, and infrared microspectroscopy identified MP particles in 33 out of 40 samples (covering the cervical, thoracic, and lumbar vertebrae, as well as the upper and lower limb bones). These detected MPs exhibited a granular morphology, with particle sizes ranging from 10 to 20 μm, predominantly composed of polyethylene and polypropylene, with 2-3 MPs/2 g bone tissues in each sample. To explore the underlying mechanisms, transcriptomic profiling of femoral tissues from MP-PE-fed mice revealed 870 up-regulated and 930 down-regulated genes, which were enriched in the hematopoietic cell lineage, NF-κB, PPAR, PI3K-Akt, and HIF-1 signaling pathways, and metabolic pathways. In vitro validation further demonstrated that MPs enhanced osteoclast differentiation by modulating the RANKL/OPG axis in bone marrow stromal cells, thereby activating the RANK-NFATc1 signaling pathway in Raw264.7 cells. These findings provide experimental and theoretical evidence of the detrimental impact of MPs on skeletal health, underscoring the urgent need for environmental and public health interventions.
More Papers Like This
Bridging relevance between microplastics, human health and bone metabolism: Emerging threats and research directions
AI summary Read the abstract
Researchers reviewed how microplastics — tiny plastic fragments that accumulate in tissues throughout the body — may disrupt bone metabolism by triggering inflammation, oxidative stress, and hormonal interference, raising concern that widespread microplastic exposure could contribute to bone diseases like osteoporosis.
Exploring the Relationship Between Microplastic Exposure and Bone Health
AI summary Read the abstract
Researchers reviewed accumulating evidence linking microplastic and nanoplastic exposure to disrupted bone homeostasis, finding that while direct epidemiological links to osteoporosis remain sparse, human biomonitoring studies of co-occurring plastic-associated endocrine disruptors such as phthalates and bisphenols consistently associate with lower bone mineral density and altered bone turnover markers.
Potential threats of environmental microplastics to the skeletal system: current insights and future directions
AI summary Read the abstract
This review summarizes emerging evidence that micro- and nanoplastics may reach the skeletal system through the bloodstream and accumulate in bone tissue. Researchers highlight potential effects on bone-forming and bone-resorbing cells, which could disrupt normal bone maintenance. The study calls attention to an underexplored area of microplastic health research and outlines directions for future investigation.
Effects of microplastics on the bones: a comprehensive review
AI summary Read the abstract
This comprehensive review examines the growing evidence that micro- and nanoplastics can affect bone health, with researchers recently detecting plastic particles in human bone tissue for the first time. Lab studies show that microplastics can trigger inflammation, increase bone-resorbing cell activity, impair bone-forming cells, and weaken bone structure in animal models. While direct links to human bone conditions like osteoporosis have not yet been confirmed, the accumulating evidence suggests that microplastic exposure may represent a new risk factor for skeletal health.
Microplastics induce osteoporosis via dose‐divergent mechanisms: Multi‐omics reveal metabolic compensation and inflammatory senescence
AI summary Read the abstract
Rats given high doses of polystyrene microplastics for four weeks showed bone loss, weaker bone-forming cells, and disrupted bone-resorbing cells, along with changes in metabolism and inflammation-linked aging processes. Lower doses caused minimal effects. Researchers identified two chemical changes that could serve as early markers of microplastic-related bone damage.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.